Medrx Co., Ltd. Statistics
Want to see JP:4586 full AI Analyst Report?
Medrx Co., Ltd. (4586) Stock Statistics & Valuation Metrics
Total Valuation
Medrx Co., Ltd. has a market cap or net worth of JPY 3.71B. The enterprise value is JPY 2.56B.
- Market Cap
- JPY 3.71B
- Enterprise Value
- JPY 2.56B
Share Statistics
Medrx Co., Ltd. has 74,147,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 74,147,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Medrx Co., Ltd.’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -45.28%.
- Return on Equity (ROE)
- -0.46
- Return on Assets (ROA)
- -0.43
- Return on Invested Capital (ROIC)
- -45.28%
- Return on Capital Employed (ROCE)
- -0.45
- Revenue Per Employee
- 6.10M
- Profits Per Employee
- -44.64M
- Employee Count
- 21
- Asset Turnover
- 0.06
- Inventory Turnover
- 0.89
Valuation Ratios
The current PE Ratio of Medrx Co., Ltd. is -3.58. Medrx Co., Ltd.’s PEG ratio is -0.12.
- PE Ratio
- -3.58
- PS Ratio
- 187.17
- PB Ratio
- 2.11
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.12
Income Statement
In the last 12 months, Medrx Co., Ltd. had revenue of 128.08M and earned -937.37M in profits. Earnings per share was -17.44.
- Revenue
- 128.08M
- Gross Profit
- 113.01M
- Operating Income
- -942.00M
- Pretax Income
- -925.05M
- Net Income
- -937.37M
- EBITDA
- -928.13M
- Earnings Per Share (EPS)
- -17.44
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Medrx Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -31.16%
Stock Price Statistics
- Beta
- 1.41
- 52-Week Price Change
- -62.10%
- 50-Day Moving Average
- 52.90
- 200-Day Moving Average
- 70.97
- Relative Strength Index (RSI)
- 56.83
- Average Volume (3m)
- 1.06M
Important Dates
Medrx Co., Ltd. upcoming earnings date is Feb 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2026
- Next Earnings Date
- Feb 05, 2027
- Ex-Dividend Date
- ―
Financial Position
Medrx Co., Ltd. as a current ratio of 23.62, with Debt / Equity ratio of 0.00%
- Current Ratio
- 23.62
- Quick Ratio
- 23.40
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.89
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Medrx Co., Ltd. has paid 12.32M in taxes.
- Income Tax
- 12.32M
- Effective Tax Rate
- -0.01
Enterprise Valuation
Medrx Co., Ltd. EV to EBITDA ratio is -1.94, with an EV/FCF ratio of 0.00.
- EV to Sales
- 93.65
- EV to EBITDA
- -1.94
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Medrx Co., Ltd. has JPY 1.14B in cash and marketable securities with JPY 0.00 in debt, giving a net cash position of JPY 1.14B billion.
- Cash & Marketable Securities
- JPY 1.14B
- Total Debt
- JPY 0.00
- Net Cash
- JPY 1.14B
- Net Cash Per Share
- JPY 15.42
- Tangible Book Value Per Share
- JPY 26.72
Margins
Gross margin is 50.40%, with operating margin of -4852.95%, and net profit margin of -4395.18%.
- Gross Margin
- 50.40%
- Operating Margin
- -4852.95%
- Pretax Margin
- -4342.02%
- Net Profit Margin
- -4395.18%
- EBITDA Margin
- -4816.85%
- EBIT Margin
- -4852.95%
Analyst Forecast
The average price target for Medrx Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -81.42%
- EPS Growth Forecast
- 36.56%
Scores
- Smart Score
- ―
- AI Score
- 46

